Skip to main content
BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
5.55
-0.10 (-1.77%)
At close: Nov 13, 2026, 4:00 PM EST
5.37
-0.18 (-3.32%)
After-hours: Nov 13, 2026, 7:53 PM EST

BioAge Labs Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
8.69---
Revenue Growth
45.33%----
Gross Profit
-90.91-64.97-59.04-33.89-
Operating Income
-120.54-92.78-78.19-48.4-39.97
Net Income
-107.8-80.61-71.11-63.85-39.72
Earnings Per Share
-2.54-2.24-6.63-38.17-23.76
EPS Growth
-----

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
352.32285.13354.3521.6427.64
Total Debt
2.735.568.753.252.47
Net Cash (Debt)
349.59279.57345.65-31.6125.18
Net Cash Growth
21.08%-19.12%---
Net Cash Per Share
8.257.7832.22-18.9015.06

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-102.52-81.63-51.52-37.36-36.18
Capital Expenditures
-0.48-0.72-0.37-0.17-0.1
Free Cash Flow
-103-82.35-51.89-37.53-36.28
Free Cash Flow Growth
-----

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22
Operating Margin
-1401.81%-1031.46%---
Pretax Margin
-1253.60%-896.11%---
Profit Margin
-1253.60%-896.11%---
FCF Margin
-1197.81%-915.46%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22
PS Ratio
29.6652.74---